Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T79051
|
|||||
Target Name |
EWS-FLI1 fusion gene mRNA (EWS-FLI1 mRNA)
|
|||||
Gene Name |
EWS-FLI1
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Ewing sarcoma [ICD-11: 2B52] | |||||
BioChemical Class |
mRNA target
|
|||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | pbi-shRNA EWS-FLI-Type 1 | Drug Info | Phase 1 | Ewing sarcoma | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | pbi-shRNA EWS-FLI-Type 1 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | National Cancer Institute Drug Dictionary (drug id 780967). | |||||
REF 2 | ClinicalTrials.gov (NCT02736565) Pbi-shRNA EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.